Results 31 to 40 of about 98,054 (191)
Value in Health, 2018 BACKGROUND Despite evidence of nonproportional trade-offs in time trade-off exercises and the explicit incorporation of exponential discounting in health technology assessment calculations, quality-adjusted life-year (QALY) tariffs are currently still ...
M. Jonker +3 more
semanticscholar +1 more source
International experience in determining the cost-effectiveness thresholds
Фармакоэкономика, 2019 The article reviews international methodological guidelines, regulatory documents and existing approaches to the determination of the costeffectiveness threshold (CeT), also known as the willingness-to-pay threshold (WTP), the threshold value of the ...
T. P. Bezdenezhnykh +5 more
doaj +1 more source
Value in Health, 2009 The aim of this article is to review the concept of the qualityadjusted life-year (QALY), a widely used measure of health improvement that is used to guide health-care resource allocation decisions. The QALY was originally developed as a measure of health effectiveness for cost-effectiveness analysis, a method intended to aid decision-makers charged ...
Weinstein, Milton C. +2 more
openaire +2 more sources
Health and Quality of Life Outcomes, 2017 BackgroundQuality-adjusted life years (QALY) is a single value index that quantifies the overall burden of disease. It reflects all aspects of heath, including nonfatal illness and mortality outcomes by weighting life-years lived with health-related ...
Haomiao Jia, Erica I. Lubetkin
semanticscholar +1 more source
THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES
Фармакоэкономика, 2017 This report addresses the ways of calculating QALY (Quality-adjusted life-year). OutsideRussia, a standardized methodology to calculate QALY is in use; such an approach makes it possible to apply this universal criterion of effectiveness to the ...
N. Z. Musina, V. K. Fedyaeva
doaj +1 more source
Why the Coming Debate Over the QALY and Disability Will be Different
Journal of Law, Medicine & Ethics, 2019 The QALY has served for over 30 years as the gold standard within health economics for measuring the impact of treatments on patients’ health. Created with the explicit goal of capturing the impact of treatment on both length of life and quality of life,
S. Pearson
semanticscholar +1 more source
Setting Dead at Zero: Applying Scale Properties to the QALY Model
Medical decision making, 2018 Introduction. Scaling severe states can be a difficult task. First, the method of measurement affects whether a health state is considered better or worse than dead.
Bram Roudijk, A. Donders, P. Stalmeier
semanticscholar +1 more source
European Journal of Health Economics, 2018 Evidence has accumulated documenting loss aversion for monetary and, recently, for health outcomes—meaning that, generally, losses carry more weight than equally sized gains.
S. Lipman, W. Brouwer, A. Attema
semanticscholar +1 more source
PLoS ONE, 2022 Background Decision-making in healthcare policy involves assessing both costs and benefits. In determining the cost-effectiveness (CE) threshold, willingness to pay (WTP) per quality-adjusted life year (QALY), GDP per capita, and other factors are ...
Haru Iino +2 more
doaj +2 more sources
Estimating a constant WTP for a QALY—a mission impossible?
European Journal of Health Economics, 2017 Economic evaluations are an important input to decision-making and priority-setting in the health care sector. Measuring preferences for health improvements, as the demand-side value (willingness to pay) of gaining a quality-adjusted life year (QALY ...
Björn Sund, M. Svensson
semanticscholar +1 more source